Tumor Shrinkage as a Prognostic Factor of Metastatic Renal Cell Carcinoma in the Era of Molecular Targeted Therapy
We evaluated the impact of tumor shrinkage (TS) induced by molecular targeted therapy as the first-line systemic therapy on the survival of patients with metastatic renal cell carcinoma (mRCC). A total of 67 patients with mRCC who received first-line molecular targeted therapy were included in this...
Description complète
Détails bibliographiques
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 67(2021), 2 vom: 01. Feb., Seite 57-61
|
|---|
| Auteur principal: |
Morooka, Daichi
(Auteur) |
|---|
| Autres auteurs: |
Takahashi, Atsushi,
Kurisu, Tomoyo,
Okabe, Ko,
Kyoda, Yuki,
Takagi, Yoshio |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | Japanese |
|---|
| Publié: |
2021
|
|---|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Sujets: | Journal Article |
|---|